Ampio Pharmaceuticals, Inc. (NY:AMPE)

N/A UNCHANGED

Last Price Updated: 8:00 PM EDT, Apr 12, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Ampio Pharmaceuticals, Inc.

< Previous 1 2 Next >

NYSE:AMPE Long Term Investor Notice: Investigation of Potential Wrongdoing at Ampio Pharmaceuticals, Inc. ↗

December 01, 2022

San Diego, CA -- (SBWIRE) -- 12/01/2022 -- An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Ampio Pharmaceuticals, Inc..

Via SBWire

NYSE:AMPE Investor Notice: Deadline on October 17, 2022 in Lawsuit Against Ampio Pharmaceuticals, Inc. ↗

October 17, 2022

San Diego, CA -- (SBWIRE) -- 10/17/2022 -- A deadline is coming up on October 17, 2022 in the lawsuit filed for certain investors of Ampio Pharmaceuticals, Inc. (NYSE:AMPE).

Via SBWire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 16, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

AMPE FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action - AMPE

October 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

AMPIO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

October 14, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

October 14, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Ampio Pharmaceuticals, Inc. (AMPE) Investors of Class Action and to Actively Participate

October 14, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against MINISO, Co-Dx, Ampio, and Sinovac and Encourages Investors to Contact the Firm

October 11, 2022

From Bragar Eagel & Squire

Via GlobeNewswire

ROSEN, A TOP RANKED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

October 08, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

October 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

October 02, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

AMPE INVESTOR NEWS: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 26, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

AMPE EQUITY ALERT: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 21, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, A LONGSTANDING LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 17, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 10, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

NYSE:AMPE Investor Notice: Lawsuit Alleges Securities Laws Violations by Ampio Pharmaceuticals, Inc. ↗

September 07, 2022

San Diego, CA -- (SBWIRE) -- 09/07/2022 -- An investor, who purchased shares of Ampio Pharmaceuticals, Inc. (NYSE:AMPE), filed a lawsuit over alleged violations of Federal Securities Laws by Ampio...

Via SBWire

ROSEN, A TOP RANKED LAW FIRM, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

September 05, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMPE

August 29, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ampio Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AMPE

August 27, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

August 26, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Ampio Pharmaceuticals, Inc. (AMPE) Investors of Class Action and to Actively Participate

August 26, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Ampio Pharmaceuticals, Inc. (AMPE)

August 24, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 23, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 22, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Ampio Pharmaceuticals, Inc. (AMPE) Investors

August 22, 2022

From Law Offices of Howard G. Smith

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Ampio Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

August 19, 2022

From The Schall Law Firm

Via Business Wire

AMPIO ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ampio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

August 18, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors

August 18, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ampio Pharmaceuticals, Inc. (AMPE) on Behalf of Investors

August 18, 2022

From Law Offices of Howard G. Smith

Via Business Wire

Stockholder Alert: Robbins LLP Reminds Investors it Has Filed a Securities Fraud Lawsuit Against Ampio Pharmaceuticals, Inc.

August 18, 2022

From Robbins LLP

Via Business Wire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.